The Phase I trial will study target dose levels of 5 mg/kg, 10 mg/kg and 20 mg/kg of PGN-EDODM1, with safety, transcript splicing and clinical outcome measures data from the 5 mg/kg cohort expected in 2024
Third-Party Testing Because the FDA does not regulate supplements, third-party testing provides independent verification of a NAD+ supplements safety, purity, and label accuracy
It can also accelerate degenerative processes and result in early wrinkles, fine lines and age spots
Increase in Muscle Mass Lets talk about muscle gains
A series of 2 to 6 treatments may be recommended for optimal results, depending on the specific treatment and individual needs
Somatostatin (the natural GH inhibitor) still functions as a brake on GH production